Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5901–5950 of 75406
On April 25, 2025, the Board of Directors (the “Board”) of F5 reviewed and accepted the resignation of Peter Klein from his position as a director of the Company, including his membership on the Audit Committee, effective April 25, 2025.
George C. Bobb III has become Teledyne’s President and Chief Executive Officer.
Edwin Roks has retired as Teledyne’s Chief Executive Officer and will continue as a special advisor to the Executive Chairman through August 31, 2025.
Also on April 25, 2025, Barbara Shattuck Kohn and Saul Reibstein notified the Board of their respective decision not to stand for reelection to the Board at the expiration of their respective current term at the Company’s 2025 annual meeting of shareholders
Also on April 25, 2025, Barbara Shattuck Kohn and Saul Reibstein notified the Board of their respective decision not to stand for reelection to the Board at the expiration of their respective current term at the Company’s 2025 annual meeting of shareholders
On April 25, 2025, Ronald J. Naples resigned from the Board of Directors (the “Board”) of PENN Entertainment, Inc. (the “Company”) effective immediately.
the Board approved, effective April 28, 2025, an increase in the size of the Board from seven (7) directors to eight (8) directors and appointed Merdad Parsey, M.D., Ph.D. to fill the newly created vacancy on the Board
On April 23, 2025, Carl L. Gordon, Ph.D., CFA notified the board of directors (the “Board”) of ArriVent BioPharma, Inc. (the “Company”) of his decision not to stand for re-election to the Board at the end of his current term at the Company’s 2025 annual meeting of stockholders currently expected to be held on June 18, 2025
appointed Mr. David Hallal as Chief Executive Officer of the Company effective as of April 27, 2025
Dr. Jay T. Backstrom’s transition from his role as the Company’s Chief Executive Officer and President to Senior Advisor on the Transition Date.
appointed Akshay Vaishnaw, a current member of the Board, as the Company’s President of Research & Development
Dr. Backstrom also resigned as a member of the Board on the Transition Date.
On April 22, 2025, Noelle K. Eder notified the Board of Directors of Ameren Corporation (the "Company") that she was resigning as a director of the Company, effective as of May 6, 2025.
On April 28, 2025 , the Board appointed Mr. Carty to the Board as a Class I director, with a term expiring at the 2026 Annual Meeting.
On April 22, 2025, Ms. Noelle Eder, Executive Vice President, Global Chief Information Officer, The Cigna Group, resigned from the Company to pursue another opportunity, effective May 16, 2025.
On April 28, 2025, Spero Therapeutics, Inc. (the “Company”) announced that effective as of May 2, 2025 (the “Effective Date”), Esther Rajavelu will serve as the Company’s President and Chief Executive Officer.
the Board appointed Ashley McEvoy as President and Chief Executive Officer of the Company and as a member of the Board as a Class III Director.
James R. Hollingshead, who has agreed with the Board that his employment will cease effective as of April 28, 2025, and resigned from the Board.
announced that Kevin Harkenrider, the Company’s Executive Vice President and Chief Corporate Officer, will retire from such role on June 30, 2025
On April 28, 2025, the Board of Directors (the “Board”) of Metsera, Inc. (the “Company”) appointed Jon P. Stonehouse to the Company’s Board, effective immediately.
On April 23, 2025, in connection with the IPO, R. Greg Smith, Andrew Clark, Harvin Moore, and Aruna Viswanathan (collectively with E. Scott Crist, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 23, 2025, in connection with the IPO, R. Greg Smith, Andrew Clark, Harvin Moore, and Aruna Viswanathan (collectively with E. Scott Crist, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 23, 2025, in connection with the IPO, R. Greg Smith, Andrew Clark, Harvin Moore, and Aruna Viswanathan (collectively with E. Scott Crist, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 23, 2025, in connection with the IPO, R. Greg Smith, Andrew Clark, Harvin Moore, and Aruna Viswanathan (collectively with E. Scott Crist, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, Daniel Springer notified Docusign, Inc. (the “Company”) of his resignation from the Company’s Board of Directors, effective immediately.
On April 23, 2025, the Board of Directors of First Western Financial, Inc. (the “Company”) designated David R. Weber, the Company’s Chief Financial Officer and Principal Financial Officer, to serve as its Principal Accounting Officer effective April 23, 2025.
Mr. Weber will assume the Principal Accounting Officer duties from Jesica J. Montgomery, who was promoted to oversee other functions within the Company.
appointed Rafael Sotomayor to succeed Mr. Sievers as President, effective April 28, 2025
appointed Rafael Sotomayor to succeed Mr. Sievers as President, effective April 28, 2025
Mr. Kurt Sievers, the CEO and President of NXP Semiconductors N.V. (the “Company”), provided notice that he would voluntarily retire as CEO and executive director of the Company on October 28, 2025.
designated Mr. Sotomayor as CEO and temporary executive director of the Company effective as of October 28, 2025
In addition, on April 30, 2025, the size of the Board will be further reduced to nine members following the previously announced retirement of Jon Kessler from the Board.
On April 22, 2025, Paul Black resigned as a member of the Board of Directors (the “Board”) of HealthEquity, Inc. (the “Company”).
On April 25, 2025, FitLife Brands, Inc. (the “ Company ”) appointed Shannon Pappas as an independent member of the Board of Directors of the Company (the “ Board ”), to serve until the next annual meeting of shareholders or until her successor is elected and qualified.
Todd Ordal, who tendered his resignation from his role as a member of the Board, effective April 25, 2025.
On April 28, 2025, MongoDB, Inc. (the “Company”) announced the appointment of Michael J. Berry as the Company’s Chief Financial Officer effective May 27, 2025.
On April 22, 2025, Mr. Christopher R. Curia, age 69, announced his intention to retire from the board of directors (the “Board”) of Sunoco GP LLC (the “General Partner”), the general partner of Sunoco LP (the “Partnership”), effective May 1, 2025.
Edward Lee, Chief Legal & Compliance Officer of RH (the “Company”), has communicated to the Company his intention to resign his position on June 20, 2025 (the “Effective Date”).
On April 23, 2025, Rusty K. Rolfe, Executive Vice President and President, Matson Logistics, notified Matson, Inc. (the “Company”) that he will retire from the Company on July 1, 2025.
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
On April 18, 2025, Michael C. Greiner announced that he will leave the Company to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.
Mr. Tang replaced Darryl Bond as the Company's Chief Accounting Officer and principal accounting officer.
appointed Allan Tang as its Chief Accounting Officer and as its principal accounting officer.
Effective upon Mr. Santoro’s appointment, Ms. Mary Doyle has resigned as the Company’s principal financial officer and principal accounting officer and her consulting agreement with the Manager has terminated.
The Board of Directors of Rithm Property Trust Inc. (the “Company”) approved the appointment of Nicola Santoro, Jr. as the Company’s Chief Financial Officer and Chief Accounting Officer, effective as of April 28, 2025.
On April 25, 2025, Amrit Nagpal notified Absci Corporation (the “Company”) that he would resign from the Company’s Board of Directors and all committees thereof, effective as of April 25, 2025.
the Board was notified by each of Michael Idelchik and Bradley Kreger of their decisions to resign as directors of the Company
the Board was notified by each of Michael Idelchik and Bradley Kreger of their decisions to resign as directors of the Company
appointed each of Jason Lloyd and Kenneth Thieneman to serve as directors of the Board to fill the vacancies created by the resignations described below.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.